会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
    • 纯化的吡咯并喹啉基 - 吡咯烷-2,5-二酮组合物及其制备和使用方法
    • US08552192B2
    • 2013-10-08
    • US12975644
    • 2010-12-22
    • David P. ReedNeil R. BarnesJohn C. KaneChristopher A. LeeJian-Xie ChenMartin P. Redmon
    • David P. ReedNeil R. BarnesJohn C. KaneChristopher A. LeeJian-Xie ChenMartin P. Redmon
    • C07D471/06
    • C07D471/04C07D471/06
    • The present invention relates to a form 1 and form 2 polymorph of (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione. The present invention also relates to (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl) pyrrolidine-2,5-dione compounds having a chiral purity greater than 99%, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising these (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a composition comprising (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione having a chiral purity greater than 99% or a form 1 and form 2 polymorph of (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione.
    • 本发明涉及( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-( -1H-吲哚-3-基)吡咯烷-2,5-二酮。 本发明还涉及( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基 )吡咯烷-2,5-二酮化合物及其制备方法。 本发明还涉及包含这些( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚 -3-基)吡咯烷-2,5-二酮化合物。 本发明提供了通过向有需要的受试者施用治疗有效量的包含( - ) - 反式-3-(5,6-二氢-4H-吡喃并[ 吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮,手性纯度大于99%,形式1和形式2 ( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2 ,5-二酮。
    • 2. 发明申请
    • Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same
    • 纯化的吡咯并喹啉基 - 吡咯烷-2,5-二酮组合物及其制备和使用方法
    • US20110160242A1
    • 2011-06-30
    • US12975644
    • 2010-12-22
    • David P. ReedNeil R. BarnesJohn C. KaneChristopher A. LeeJian-Xie ChenMartin P. Redmon
    • David P. ReedNeil R. BarnesJohn C. KaneChristopher A. LeeJian-Xie ChenMartin P. Redmon
    • A61K31/473C07D471/06A61P35/00
    • C07D471/04C07D471/06
    • The present invention relates to a form 1 and form 2 polymorph of (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione. The present invention also relates to (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione compounds having a chiral purity greater than 99%, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising these (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a composition comprising (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione having a chiral purity greater than 99% or a form 1 and form 2 polymorph of (−)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione.
    • 本发明涉及( - ) - 反式-3-(5,6-二氢-4H-吡咯并〔3,2,1-ij〕喹啉-1-基)-4-( -1H-吲哚-3-基)吡咯烷-2,5-二酮。 本发明还涉及( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基 )吡咯烷-2,5-二酮化合物及其制备方法。 本发明还涉及包含这些( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚 -3-基)吡咯烷-2,5-二酮化合物。 本发明提供了通过向有需要的受试者施用治疗有效量的包含( - ) - 反式-3-(5,6-二氢-4H-吡喃并[ 吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮,手性纯度大于99%,形式1和形式2 ( - ) - 反式-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2 ,5-二酮。